High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells.
Antigens, CD
/ metabolism
Atorvastatin
/ pharmacology
CTLA-4 Antigen
/ metabolism
Cells, Cultured
Cytokines
/ metabolism
Flow Cytometry
/ methods
Forkhead Transcription Factors
/ metabolism
Humans
Interleukin-2
/ metabolism
Leukocyte Common Antigens
/ metabolism
Leukocytes, Mononuclear
/ drug effects
Programmed Cell Death 1 Receptor
/ metabolism
Receptors, CCR7
/ metabolism
T-Lymphocytes, Regulatory
/ drug effects
Tumor Necrosis Factor-alpha
/ metabolism
Ca2+ flux
FoxP3
Regulatory T cell
activation
statin
Journal
Clinical and experimental immunology
ISSN: 1365-2249
Titre abrégé: Clin Exp Immunol
Pays: England
ID NLM: 0057202
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
accepted:
03
01
2019
pubmed:
15
1
2019
medline:
19
2
2020
entrez:
15
1
2019
Statut:
ppublish
Résumé
Regulatory T cells (T
Identifiants
pubmed: 30638266
doi: 10.1111/cei.13260
pmc: PMC6468172
doi:
Substances chimiques
Antigens, CD
0
CTLA-4 Antigen
0
Cytokines
0
Forkhead Transcription Factors
0
Interleukin-2
0
Programmed Cell Death 1 Receptor
0
Receptors, CCR7
0
Tumor Necrosis Factor-alpha
0
Atorvastatin
A0JWA85V8F
Leukocyte Common Antigens
EC 3.1.3.48
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
237-248Informations de copyright
© 2019 British Society for Immunology.
Références
Br J Pharmacol. 2010 Mar;159(6):1294-303
pubmed: 20136831
Front Immunol. 2017 Mar 20;8:300
pubmed: 28373873
Clin Exp Immunol. 2006 Dec;146(3):524-32
pubmed: 17100774
Nature. 2013 Jul 25;499(7459):485-90
pubmed: 23812589
J Immunol. 2008 May 15;180(10):6988-96
pubmed: 18453621
Mol Med. 2012 May 09;18:598-605
pubmed: 22331026
J Immunol. 2003 Apr 15;170(8):3939-43
pubmed: 12682220
Nephrol Dial Transplant. 2003 May;18(5):967-76
pubmed: 12686673
Ann Rheum Dis. 2012 May;71(5):648-54
pubmed: 21979000
Biochem Pharmacol. 2013 May 15;85(10):1513-24
pubmed: 23537702
Nat Rev Immunol. 2006 May;6(5):358-70
pubmed: 16639429
Immunology. 2010 Aug;130(4):484-93
pubmed: 20408897
Sci Rep. 2015 Nov 30;5:17381
pubmed: 26616555
J Immunol. 2007 Sep 15;179(6):3613-21
pubmed: 17785796
J Exp Med. 2006 Feb 20;203(2):401-12
pubmed: 16476765
Front Immunol. 2015 Aug 21;6:418
pubmed: 26347741
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):E4662-70
pubmed: 27462110
J Lipid Res. 2011 May;52(5):1023-32
pubmed: 21368320
Cell Biosci. 2014 Sep 01;4:51
pubmed: 25908962
Pharmacol Res. 2014 Oct;88:3-11
pubmed: 24657242
J Immunol. 2008 Sep 1;181(5):3524-34
pubmed: 18714025
FASEB J. 2005 Apr;19(6):605-7
pubmed: 15677697
Int Immunol. 2009 Jun;21(6):679-89
pubmed: 19380384
Atherosclerosis. 2008 Apr;197(2):829-39
pubmed: 17826781
Cell. 2008 May 30;133(5):775-87
pubmed: 18510923
Cell. 2000 May 26;101(5):455-8
pubmed: 10850488
Nat Immunol. 2002 Jan;3(1):33-41
pubmed: 11740498
Nat Rev Immunol. 2007 Sep;7(9):690-702
pubmed: 17703229
BMJ. 2003 Jun 28;326(7404):1423
pubmed: 12829554
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):893-900
pubmed: 17272749
BMC Cardiovasc Disord. 2016 Jan 29;16:26
pubmed: 26822994
Int J Inflam. 2013;2013:434586
pubmed: 24159421
Nat Immunol. 2007 Mar;8(3):277-84
pubmed: 17220892
Sci Adv. 2015 Nov 06;1(10):e1500845
pubmed: 26601142
PLoS One. 2015 Nov 03;10(11):e0141864
pubmed: 26529512
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9579-84
pubmed: 24979767
Mediators Inflamm. 2015;2015:841472
pubmed: 26063978
Clin Exp Immunol. 2011 Nov;166(2):291-8
pubmed: 21985375
J Immunol. 2002 Feb 1;168(3):1080-6
pubmed: 11801641
Clin Lab Med. 2007 Sep;27(3):469-85, v
pubmed: 17658403
Lancet. 2004 Feb 21;363(9409):608-15
pubmed: 14987885
Molecules. 2017 Nov 10;22(11):
pubmed: 29125561
J Immunol Res. 2015;2015:762506
pubmed: 25759848
J Leukoc Biol. 2016 Jul;100(1):5-16
pubmed: 26715685